BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29387884)

  • 1. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
    van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
    JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to Surgery and Breast Cancer Survival in the United States.
    Bleicher RJ; Ruth K; Sigurdson ER; Beck JR; Ross E; Wong YN; Patel SA; Boraas M; Chang EI; Topham NS; Egleston BL
    JAMA Oncol; 2016 Mar; 2(3):330-9. PubMed ID: 26659430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race.
    Zhou J; Cueto J; Ko NY; Hoskins KF; Nabulsi NA; Asfaw AA; Hubbard CC; Mitra D; Calip GS; Law EH
    Breast; 2021 Oct; 59():367-375. PubMed ID: 34419726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.
    Sherman ME; Vierkant RA; Winham SJ; Vachon CM; Carter JM; Pacheco-Spann L; Jensen MR; McCauley BM; Hoskin TL; Seymour L; Gehling D; Fischer J; Ghosh K; Radisky DC; Degnim AC
    JAMA Surg; 2024 Feb; 159(2):193-201. PubMed ID: 38091020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
    Kurian AW; Lichtensztajn DY; Keegan TH; Nelson DO; Clarke CA; Gomez SL
    JAMA; 2014 Sep; 312(9):902-14. PubMed ID: 25182099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.
    Kim Y; Ganduglia-Cazaban C; Tamirisa N; Lucci A; Krause TM
    Ann Surg Oncol; 2024 Jun; 31(6):3649-3660. PubMed ID: 38319511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of SEER Treatment Data With Medicare Claims.
    Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
    Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence.
    Haskins CB; Neuner JM; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA
    Clin Breast Cancer; 2020 Jun; 20(3):e261-e280. PubMed ID: 32139273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managed care and cancer outcomes for Medicare beneficiaries with disabilities.
    Roetzheim RG; Chirikos TN; Wells KJ; McCarthy EP; Ngo LH; Li D; Drews RE; Iezzoni LI
    Am J Manag Care; 2008 May; 14(5):287-96. PubMed ID: 18471033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.
    Elkin EB; Ishill N; Riley GF; Bach PB; Gonen M; Begg CB; Schrag D
    J Natl Cancer Inst; 2008 Jul; 100(14):1013-21. PubMed ID: 18612131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database.
    Beachler DC; Yanik EL; Martin BI; Pfeiffer RM; Mirza SK; Deyo RA; Engels EA
    J Bone Joint Surg Am; 2016 Jul; 98(13):1064-72. PubMed ID: 27385679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
    Leone J; Hassett MJ; Freedman RA; Tolaney SM; Graham N; Tayob N; Vallejo CT; Winer EP; Lin NU; Leone JP
    JAMA Oncol; 2024 Apr; 10(4):508-515. PubMed ID: 38421673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preexisting mental illness on breast cancer endocrine therapy adherence.
    Haskins CB; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA
    Breast Cancer Res Treat; 2019 Feb; 174(1):197-208. PubMed ID: 30465157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and Complications of Local Therapies for Early-Stage Breast Cancer.
    Smith BD; Jiang J; Shih YC; Giordano SH; Huo J; Jagsi R; Momoh AO; Caudle AS; Hunt KK; Shaitelman SF; Buchholz TA; Shirvani SM
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27678203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis.
    Neuman HB; Schumacher JR; Schneider DF; Winslow ER; Busch RA; Tucholka JL; Smith MA; Greenberg CC
    Ann Surg Oncol; 2017 Mar; 24(3):683-691. PubMed ID: 27709403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast MRI utilization in older patients with newly diagnosed breast cancer.
    Sommer CA; Stitzenberg KB; Tolleson-Rinehart S; Carpenter WR; Carey TS
    J Surg Res; 2011 Sep; 170(1):77-83. PubMed ID: 21658724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient.
    Churilla TM; Egleston BL; Murphy CT; Sigurdson ER; Hayes SB; Goldstein LJ; Bleicher RJ
    Breast Cancer Res Treat; 2016 Nov; 160(1):153-162. PubMed ID: 27640196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between diabetes and subsequent malignancy risk among older breast cancer survivors.
    Hardell KNL; Schonfeld SJ; Ramin C; Vo JB; Morton LM
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38718185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of Insurance Coverage and the Risk of Amputation in Patients with Pre-Existing Commercial Health Insurance and Peripheral Artery Disease.
    Howell C; Lane A; Weinkauf C; Armstrong DG; Arias JC; Tan TW
    Ann Vasc Surg; 2023 Oct; 96():284-291. PubMed ID: 37023922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
    Hussain A; Yong C; Tkaczuk KHR; Qian Y; Arellano J; Mullins CD; Onukwugha E
    PLoS One; 2018; 13(3):e0193661. PubMed ID: 29494653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.